Number of commercial banks’ clients in Armenia shrinks 6.4% over June 2014 to 1.9 million

YEREVAN, September 4. /ARKA/. The number of commercial banks’ clients in Armenia contracted by 6.4% over June 2014 to 1,915,274 by the end of the month, the National Statistical Service reports.

The country’s commercial banks had 72,654 corporate clients and 1,842,620 individual clients in late June.

They had 3,261,658 accounts (6.8% reduction over the month) – 3,098,643 belonging to individuals and 163,015 to corporate clients.

According to the statistical report, balances on the population’s deposits in banks totaled AMD 847.9 billion in late July after growing 0.4% or by AMD 3536 million over the month and 17.9% or by AMD 128716 million, compared with the same month a year before. ($1 – AMD 410.15). –0–

spot_img

POPULAR

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img